Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).
Giussani G, Bianchi E, Carlando E, DiFrancesco JC, Tabaee Damavandi P, Pasini F, Pederzoli G, Filipponi S, Gaiani A, Massacesi L, Rosati E, Giovannelli G, Cantisani TA, Cecconi M, Papetti R, Brioschi M, Aruta F, Agostoni EC, Paladin F, Dainese F, Longoni M, Yerma B, Gasparini S, Aguglia U, Ferlazzo E, Cantello R, Strigaro G, Maschio M, Benincasa D, La Neve A, Falcicchio G, Giordano A, Buttarelli L, Enia G, Leone M, Ferrarese C, Beghi E, Beretta S.
Giussani G, et al. Among authors: cantisani ta.
Epilepsia Open. 2025 Apr;10(2):643-653. doi: 10.1002/epi4.70016. Epub 2025 Feb 27.
Epilepsia Open. 2025.
PMID: 40013886
Free PMC article.
Clinical Trial.